{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T02:05:20Z","timestamp":1793066720090,"version":"4.5.0"},"reference-count":76,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"4","license":[{"start":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T00:00:00Z","timestamp":1564444800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7,30]]},"abstract":"<jats:title>Summary<\/jats:title><jats:sec id=\"j_jomb-2019-0002_s_005\"><jats:title>Background<\/jats:title><jats:p>Chronic kidney disease (CKD) is associated with numerous complications such as bone mineral disorder. The aim of our study was to analyze the correlation of bone turnover markers with Bone Mineral Density (BMD) measurements in Tunisian end stage renal diseases (ESRD) patients.<\/jats:p><\/jats:sec><jats:sec id=\"j_jomb-2019-0002_s_006\"><jats:title>Methods<\/jats:title><jats:p>This study included 100 ESRD Tunisian patients. Their estimated glomerular filtration rate (eGFR) was &lt; 15 mL \u00d7 min<jats:sup>-1<\/jats:sup>\u00d7 (1.73 m<jats:sup>2<\/jats:sup>)<jats:sup>-1<\/jats:sup>, which requires hemodialysis. Bone-specific alkaline phosphatase (BALP) serum concentration was determined with a chemiluminescence immunoassay. Fibroblast Growth Factor 23 (FGF23) serum was assessed by Enzyme-Linked Immunosorbent Assay method. The serum levels of 25-Hydroxyvitamin D (25(OH)D), intact parathyroid hormone (iPTH) and Beta cross-laps (CTX) was measured by Electrochemiluminescence Technology. DEXA (dual-energy x-ray absorptiometry) technique was used to evaluate BMD.<\/jats:p><\/jats:sec><jats:sec id=\"j_jomb-2019-0002_s_007\"><jats:title>Results<\/jats:title><jats:p>We observed a statistically significant negative correlation between BALP levels and total body BMD (r = -0.268; P = 0.015) particularly in femoral neck (FN) (r = -0.219; P = 0.037). BALP concentrations were negatively associated with total BMD especially in FN for patients with BMI &lt; 30, FGF23 concentrations were also negatively correlated with BMD in lumbar spine site (LS) (r = -0.209; P = 0.046). For osteopenic patients we found an inverse correlation between 25(OH)D concentrations and BMD in LS position (r = -0.336; P = 0.038). In men group, we have also found a negative correlation between iPTH and total BMD (r = -0.326; P = 0.015). However we found a positive correlation between calcium expression and BMD in LS site (r = 0.270; P = 0.031).<\/jats:p><\/jats:sec><jats:sec id=\"j_jomb-2019-0002_s_008\"><jats:title>Conclusions<\/jats:title><jats:p>FGF23 and BALP can predict bone loss in ESRD through their strong correlation with BMD in LS and FN sites respectively.<\/jats:p><\/jats:sec>","DOI":"10.2478\/jomb-2019-0002","type":"journal-article","created":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T10:07:58Z","timestamp":1550052478000},"page":"418-426","source":"Crossref","is-referenced-by-count":13,"title":["Correlation of fgf23 and balp with bone mineral density in hemodialysis patients"],"prefix":"10.5937","volume":"38","author":[{"given":"Mouna","family":"Bouksila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Mrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wajih","family":"Kaabachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eya","family":"Kalai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wided","family":"Smaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Rekik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Krir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nesrine","family":"Issaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Hamzaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hela","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elhem Cheour El","family":"Kateb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed Karim","family":"Zouaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afef","family":"Bahlous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3964","reference":[{"key":"ref641","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0036-1592370","article-title":"Adult Dual-Energy X-ray Absorptiometry in Clinical Practice: How I Report it","volume":"20","year":"2016","journal-title":"Semin Musculoskelet Radiol"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","year":"2013","journal-title":"J Bone Miner Res"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","article-title":"Useful biochemical markers for diagnosing renal osteodystrophy in pre-dialysis end-stage renal failure patients","volume":"41","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"ref251","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1055\/s-0036-1592370","article-title":"Adult Dual-Energy X-ray Absorptiometry in Clinical Practice: How I Report it","volume":"20","year":"2016","journal-title":"Semin Musculoskelet Radiol"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-62703-562-0_3","article-title":"Multisystemic functions of alkaline phosphatases","volume":"1053","year":"2013","journal-title":"Methods Mol Biol"},{"key":"ref401","first-page":"737","article-title":"KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"70","journal-title":"Am J Kidney Dis 2017;"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5414\/CNP65235","article-title":"Renal osteodystrophy: what\u2019s in a name? Presentation of a clinically useful new model to interpret bone histologic findings","volume":"65","year":"2006","journal-title":"Clin Nephrol"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","year":"2006","journal-title":"Nat Genet"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"R1365","DOI":"10.1152\/ajpregu.2000.279.4.R1365","article-title":"Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1","volume":"279","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1359\/jbmr.090203","article-title":"Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw","volume":"24","year":"2009","journal-title":"J Bone Miner Res"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/jomb-2017-0041","article-title":"Association between vitamin D deficiencies in sarcoidosis with disease activity, course of disease and stages of lung involvements","volume":"37","year":"2018","journal-title":"J Med Biochem"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11914-011-0053-4","article-title":"FGF23 in skeletal modeling and remo - deling","volume":"9","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"ref481","article-title":"Dual roles of the mineral metabolism disorders biomarkers in prevalent hemodilysis patients: in renal bone disease and in vascular calcification","volume":"38","year":"2019","journal-title":"J Med Biochem"},{"key":"ref11","first-page":"737","article-title":"KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"70","journal-title":"Am J Kidney Dis 2017;"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/00365513.2017.1354256","article-title":"Effects of parathyroidectomy on bone metabolism in haemodialysis patients with secondary hyperparathyroidism","volume":"77","year":"2017","journal-title":"Scand J Clin Lab Invest"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/jbmr.1916","article-title":"Rapid cortical bone loss in patients with chronic kidney disease","volume":"28","year":"2013","journal-title":"J Bone Miner Res"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.1.07059","article-title":"Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity","volume":"192","year":"2007","journal-title":"J Endocrinol"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0272-6386(03)00197-5","article-title":"Useful biochemical markers for diagnosing renal osteodystrophy in pre-dialysis end-stage renal failure patients","volume":"41","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00467-012-2309-3","article-title":"FGF23 production by osteocytes","volume":"28","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.lfs.2005.02.007","article-title":"Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH","volume":"77","year":"2005","journal-title":"Life Sci"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"R1365","DOI":"10.1152\/ajpregu.2000.279.4.R1365","article-title":"Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1","volume":"279","year":"2000","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"255\u2013","DOI":"10.1007\/s40620-016-0292-7","article-title":"Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis","volume":"30","year":"2017","journal-title":"J Nephrol"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1542-4758.2009.00430.x","article-title":"Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients","volume":"14","year":"2010","journal-title":"Hemodial Int"},{"key":"ref91","article-title":"Dual roles of the mineral metabolism disorders biomarkers in prevalent hemodilysis patients: in renal bone disease and in vascular calcification","volume":"38","year":"2019","journal-title":"J Med Biochem"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bone.2003.10.005","article-title":"MEPE has the properties of an osteoblastic phosphatonin and minhibin","volume":"34","year":"2004","journal-title":"Bone"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/00365513.2017.1354256","article-title":"Effects of parathyroidectomy on bone metabolism in haemodialysis patients with secondary hyperparathyroidism","volume":"77","year":"2017","journal-title":"Scand J Clin Lab Invest"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","year":"2006","journal-title":"Nat Genet"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1515\/jomb-2017-0041","article-title":"Association between vitamin D deficiencies in sarcoidosis with disease activity, course of disease and stages of lung involvements","volume":"37","year":"2018","journal-title":"J Med Biochem"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ijos.2015.1","article-title":"Fibroblast growth factor 23 and bone mineralisation","volume":"7","year":"2015","journal-title":"Int J Oral Sci"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00198-005-0047-0","article-title":"Osteoprotegerin and bone mineral density in hemodialysis patients","volume":"17","year":"2006","journal-title":"Osteoporos Int"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ndt\/gfx080","article-title":"Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2\u20135 and on dialysis","volume":"32","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"ref741","first-page":"79","article-title":"Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients","volume":"24","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11914-011-0053-4","article-title":"FGF23 in skeletal modeling and remo - deling","volume":"9","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ijos.2015.1","article-title":"Fibroblast growth factor 23 and bone mineralisation","volume":"7","year":"2015","journal-title":"Int J Oral Sci"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","year":"2003","journal-title":"J Biol Chem"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","article-title":"Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease","volume":"318","year":"2012","journal-title":"Exp Cell Res"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1515\/jomb-2017-0019","article-title":"Alterations of HDL particles in children with end-stage renal disease","volume":"36","year":"2017","journal-title":"J Med Biochem"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/978-1-62703-562-0_3","article-title":"Multisystemic functions of alkaline phosphatases","volume":"1053","year":"2013","journal-title":"Methods Mol Biol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/jim-2015-000043","article-title":"Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease","volume":"64","year":"2016","journal-title":"J Investig Med"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.lfs.2005.02.007","article-title":"Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH","volume":"77","year":"2005","journal-title":"Life Sci"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ndt\/gfx080","article-title":"Clinical practice recommendations for treatment with active vitamin D analogues in children with chronic kidney disease Stages 2\u20135 and on dialysis","volume":"32","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.ajkd.2009.10.049","article-title":"Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study","volume":"55","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40620-017-0408-8","article-title":"Circulating markers of bone turnover","volume":"30","year":"2017","journal-title":"J Nephrol"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000355807","article-title":"Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients","volume":"39","year":"2014","journal-title":"Kidney Blood Press Res"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.ajkd.2009.10.049","article-title":"Kidney function and rate of bone loss at the hip and spine: the Canadian Multicentre Osteoporosis Study","volume":"55","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.5414\/CNP65235","article-title":"Renal osteodystrophy: what\u2019s in a name? Presentation of a clinically useful new model to interpret bone histologic findings","volume":"65","year":"2006","journal-title":"Clin Nephrol"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1515\/jomb-2017-0007","article-title":"The effect of early substitution of subclinical hypothyroidism on biochemical blood parameters and the quality of life","volume":"36","year":"2017","journal-title":"J Med Biochem"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bone.2003.10.005","article-title":"MEPE has the properties of an osteoblastic phosphatonin and minhibin","volume":"34","year":"2004","journal-title":"Bone"},{"key":"ref331","first-page":"5949","article-title":"Osteoporosis biomarkers act as predictors for diagnosis of chronic renal insufficiency in elder patients","volume":"8","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/jim-2015-000043","article-title":"Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease","volume":"64","year":"2016","journal-title":"J Investig Med"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s40620-017-0408-8","article-title":"Circulating markers of bone turnover","volume":"30","year":"2017","journal-title":"J Nephrol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.2010121275","article-title":"Discriminants of prevalent fractures in chronic kidney disease","volume":"22","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1159\/000355807","article-title":"Significant association between bone-specific alkaline phosphatase and vascular calcification of the hand arteries in male hemodialysis patients","volume":"39","year":"2014","journal-title":"Kidney Blood Press Res"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1359\/jbmr.090203","article-title":"Assessing the clinical utility of serum CTX in postmenopausal osteoporosis and its use in predicting risk of osteonecrosis of the jaw","volume":"24","year":"2009","journal-title":"J Bone Miner Res"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1515\/jomb-2017-0045","article-title":"The Effects of Education and Training Given to Phlebotomists for Reducing Pre-analytical Errors","volume":"37","year":"2018","journal-title":"J Med Biochem"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.1.07059","article-title":"Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity","volume":"192","year":"2007","journal-title":"J Endocrinol"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00467-012-2309-3","article-title":"FGF23 production by osteocytes","volume":"28","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"ref751","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1515\/CCLM.2000.166","article-title":"Evaluation of a fully automated assay to measure C-telopeptide of type I collagen in serum","volume":"38","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","year":"2003","journal-title":"J Biol Chem"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1515\/jomb-2017-0007","article-title":"The effect of early substitution of subclinical hypothyroidism on biochemical blood parameters and the quality of life","volume":"36","year":"2017","journal-title":"J Med Biochem"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00198-005-0047-0","article-title":"Osteoprotegerin and bone mineral density in hemodialysis patients","volume":"17","year":"2006","journal-title":"Osteoporos Int"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1515\/CCLM.2000.166","article-title":"Evaluation of a fully automated assay to measure C-telopeptide of type I collagen in serum","volume":"38","year":"2000","journal-title":"Clin Chem Lab Med"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1542-4758.2009.00430.x","article-title":"Association of serum alkaline phosphatase and bone mineral density in maintenance hemodialysis patients","volume":"14","year":"2010","journal-title":"Hemodial Int"},{"key":"ref721","first-page":"5949","article-title":"Osteoporosis biomarkers act as predictors for diagnosis of chronic renal insufficiency in elder patients","volume":"8","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"255\u2013","DOI":"10.1007\/s40620-016-0292-7","article-title":"Total and bone-specific alkaline phosphatase are associated with bone mineral density over time in end-stage renal disease patients starting dialysis","volume":"30","year":"2017","journal-title":"J Nephrol"},{"key":"ref01","first-page":"293","article-title":"The role of bone biomarkers and new imaging techniques in the management of patients with CKD-MBD","volume":"31","year":"2017","journal-title":"Port J Nephrol Hypert"},{"key":"ref351","first-page":"79","article-title":"Bone mineral density and its correlation with clinical and laboratory factors in chronic peritoneal dialysis patients","volume":"24","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"ref391","first-page":"293","article-title":"The role of bone biomarkers and new imaging techniques in the management of patients with CKD-MBD","volume":"31","year":"2017","journal-title":"Port J Nephrol Hypert"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1515\/jomb-2017-0045","article-title":"The Effects of Education and Training Given to Phlebotomists for Reducing Pre-analytical Errors","volume":"37","year":"2018","journal-title":"J Med Biochem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1515\/jomb-2017-0019","article-title":"Alterations of HDL particles in children with end-stage renal disease","volume":"36","year":"2017","journal-title":"J Med Biochem"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.yexcr.2012.02.027","article-title":"Role of FGF23 in vitamin D and phosphate metabolism: implications in chronic kidney disease","volume":"318","year":"2012","journal-title":"Exp Cell Res"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.2010121275","article-title":"Discriminants of prevalent fractures in chronic kidney disease","volume":"22","year":"2011","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of Medical Biochemistry"],"original-title":[],"link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/jomb\/38\/4\/article-p418.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2019\/1452-82581904418B.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T20:28:08Z","timestamp":1662928088000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/article.aspx?artid=1452-82581904418B"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,30]]},"references-count":76,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.2478\/jomb-2019-0002","relation":{},"ISSN":["1452-8266"],"issn-type":[{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,30]]}}}